LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Lancaster Laboratories, the global leader in bio/pharmaceutical GMP product testing, and Celsis International Ltd., the global leader in rapid microbial ...
CHICAGO--(BUSINESS WIRE)--Celsis International plc, a Chicago-based life science products and services company, today announced that the US Food and Drug Administration (FDA) has accepted a Celsis ...
New EndoScan-V™ endotoxin detection software and Celsis® automated detection platform for rapid sterility introduced to address unmet industry needs WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River ...
The importance of rapid methods, particularly those designed to support microbiological practices, was made by Andrew Hopkins who is an Expert Good Manufacturing Practices inspector with the UK’s ...
– Enhances Charles River Endotoxin and Microbial Detection's Position as the Most Comprehensive Solution for Rapid Quality Control Testing – – Transaction Expected to be Accretive to Non-GAAP EPS by ...
Charles River Laboratories International ($CRL) expects to boost its position in pharma manufacturing with a $212 million deal to buy Celsis International, a company ...
– Transaction Expected to be Accretive to Non-GAAP EPS by Approximately $0.05 in 2015 and $0.15-$0.20 in 2016 – WILMINGTON, Mass.--Charles River Laboratories International, Inc. (NYSE: CRL) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results